average a1c reduction glp-1 treatment Association of Changes in Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP- 1 RA Therapy | Diabetes Therapy DID YOU KNOW? GLP-1 medications

Nearly 9 million Americans now use GLP-1 receptor agonist therapy for weight management, and the majority learn to self-inject at home

Study Outcomes The primary outcome was recurrence of AF, defined as hospitalization or outpatient visit coded for AF

These factors, combined with robust clinical evidence demonstrating efficacy in glycemic control and weight management, ensure North America retains the largest market share for GLP-1 receptor agonists globally

Therefore, although DPP-4 inhibition reduces both fasting and postprandial glucose and HbA 1c levels, the effects are weaker than for GLP-1 receptor agonists, and they do not exhibit a body weight reduction effect, although they are body weight neutral